Healthcare & Life Sciences
Sionna Therapeutics
United Stateswww.sionnatx.com/
Sionna Therapeutics is a series c plus startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2019
Founded
2
Investors
About Sionna Therapeutics
Sionna Therapeutics is a company founded in 2019 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Sionna Therapeutics is a life sciences company developing a new class of small molecules designed to fully restore the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein for the treatment of cystic fibrosis.
Explore Sionna Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.